Sort
4,870 grants matching “glp 1”
HIV FIRST GENERATION BNABS YT
$42,703,445David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA
Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study
$30,855,577John M Lachin · George Washington University · U01 · FY2018 · DK
Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study
$30,477,617John M Lachin · George Washington University · U01 · FY2017 · DK
Glycemia Reduction Approaches in Diabetes: A comparative effectiveness study
$29,980,562John M Lachin · George Washington University · U01 · FY2016 · DK
Glycemia Reduction Approaches in Diabetes: A comparative effectiveness study
$28,947,476John M Lachin · George Washington University · U01 · FY2015 · DK
Glycemia Reduction Approaches in Diabetes: A comparative effectiveness study
$27,693,077John M Lachin · George Washington University · U01 · FY2014 · DK
Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study
$26,924,216John M Lachin · George Washington University · U01 · FY2019 · DK
Glycemia Reduction Approaches in Diabetes: A comparative effectiveness study
$25,963,369John M Lachin · George Washington University · U01 · FY2013 · DK
Glycemia Reduction Approaches in Diabetes: A comparative effectiveness study
$23,251,182John M Lachin · George Washington University · U01 · FY2012 · DK
HVTN Laboratory Program
$20,409,370Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · U01 · FY2009 · AI
Animal Medicine Infrastructure Support
$19,986,524Diana Scorpio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
HVTN Laboratory Program
$17,087,386Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2011 · AI
Manufacturing of Novel Adenovirus Prime-Boost HIV-1 Vaccine
$16,612,311Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2012 · AI
HVTN Laboratory Program
$15,927,918Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · U01 · FY2008 · AI
HVTN Laboratory Program
$15,461,760Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · U01 · FY2007 · AI
HVTN Laboratory Program
$13,724,431Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · U01 · FY2010 · AI
BIOD YT
$13,600,000David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA
HVTN Laboratory Program
$13,310,092Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2012 · AI
Manufacturing of Novel Adenovirus Prime-Boost HIV-1 Vaccine
$13,210,979Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2010 · AI
A once-weekly oral methadone for maintenance therapy for opioid use disorder
$11,699,793Richard Scranton · Lyndra Therapeutics, Inc. · UH3 · FY2021 · DA
Research Services Core (RSC)
$10,999,069Samuel Michael · National Center For Advancing Translational Sciences · ZIC · FY2021 · TR
Manufacturing of Novel Adenovirus Prime-Boost HIV-1 Vaccine
$10,842,162Jaap Goudsmit · Beth Israel Deaconess Medical Center · U19 · FY2009 · AI
Cedars-Sinai Biobank and Translational Research Core Facility (CS-BRCF)
$9,552,872Shlomo Melmed · Cedars-Sinai Medical Center · G20 · FY2010 · RR
NIAAA Repository/Screening Database Management and Research
$8,672,272Melanie Schwandt · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2020 · AA
DEVELOPMENT OF AN ORAL DRUG FOR SMALLPOX TREATMENT
$8,630,636George R Painter · Chimerix, Inc. · U01 · FY2006 · AI